New hope for teens with uncontrollable seasonal allergies?
NCT ID NCT04648930
Summary
This study looked at the safety and effectiveness of the drug Xolair in teenagers with severe seasonal allergies that weren't controlled by standard allergy medicines. It involved 50 participants aged 12 to 18 and observed them for up to 24 weeks. The main goal was to see what side effects occurred and how much the drug helped improve their allergy symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.